It was noted that production of the Sputnik V two-component vaccine is planned to be 50 mln doses within the first 12 months from the date of commercialization - that is 50 mln of the first component and 50 mln of the second component
Indian Shilpa Medicare signs deal to produce Sputnik V
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться